Sanford-Burnham's disease deals

Over the past five years, the Sanford-Burnham Medical Research Institute has taken steps to position itself more like a disease-focused biotech than a not-for-profit research organization. The strategy is starting to pay dividends, as the institute has announced two partnerships-with Johnson & Johnson and Takeda Pharmaceutical Co. Ltd.-

in the past two months...